Nivolumab
Nivolumab is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.
Product Specifications
CAS Number
946414-94-4
Product Name Alternative
BMS-936558; ONO-4538; MDX-1106
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Anti-PD-1_Neutralizing_Antibody_2.html
Purity
99.63
Solubility
H2O
Smiles
[Nivolumab]
Molecular Weight
(143.62 kDa)
References & Citations
[1]Wang C, et al. In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates. Cancer Immunol Res. 2014 Sep;2 (9) :846-56.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1098120 Inquire
Recombinant Streptococcus pneumoniae serotype 19F V-type ATP synthase alpha chain (atpA), partial
Sign In for Pricing
View Details 
VAng-Ly1942-50gEcoli 50 µg (E. coli)
Recombinant Streptococcus Pneumoniae SPJ_1203 Protein (aa 1-110)
Sign In for Pricing
View Details 